Cardiovascular Risk Reclassification With the 2026 Dyslipidemia Guideline.

The 2023 PREVENT-ASCVD equations reclassify cardiovascular risk more accurately than the 2013 PCEs in NHANES data, affecting millions of adults.

• Why it matters: Accurate risk assessment is crucial for guiding lipid management and preventing cardiovascular events, yet existing models may misclassify risk levels.
• What they did: The study analyzed NHANES data to compare risk reclassification between the 2013 PCEs and the 2023 PREVENT-ASCVD equations, focusing on how many individuals are reclassified.
• The result: Findings show significant reclassification, with the new equations potentially improving risk stratification and informing better clinical decision-making for cardiovascular prevention.